Xuanwen Li

Q: What is Xuanwen Li email address?

Email Xuanwen Li at michael11idxy@gmail.com and xuanwen.li@merck.com. This email is the most updated Xuanwen Li email found in 2026.

Q: How to contact Xuanwen Li?

To contact Xuanwen Li send an email to michael11idxy@gmail.com or xuanwen.li@merck.com. (updated on October 29, 2024)

Principal Scientist at Merck | New York City Metropolitan Area

About Xuanwen Li

Xuanwen Li is a Principal Scientist at Merck, where he leverages over 20 years of extensive experience in mass spectrometry-based biotherapeutics characterization, bioanalysis, and proteomics to drive innovative solutions in vaccine and biologics development. His current role focuses on developing cutting-edge analytical enabling technologies, particularly through the application of advanced mass spectrometry techniques. Xuanwen’s expertise in analytical and bioanalytical method development is pivotal in ensuring the qualification, validation, and transfer of robust methodologies that meet regulatory standards in GxP laboratories.

Throughout his career, Xuanwen has made significant contributions to the biopharma industry, notably playing a key role in the successful approval of Portrazza™ and Lartruvo™. His proficiency in biotherapeutic protein characterization, including peptide mapping and intact mass analysis, has positioned him as a leading expert in the field. Xuanwen’s work not only enhances the understanding of complex biological systems but also facilitates the development of novel therapeutics that address unmet medical needs.

In addition to his technical skills in proteomics and clinical pharmacology, Xuanwen is adept at integrating genomic data and chemical biology insights into his research. His collaborative approach fosters cross-functional partnerships, enabling the translation of scientific discoveries into viable therapeutic solutions. As he continues to push the boundaries of analytical science at Merck, Xuanwen remains committed to advancing the field of biotherapeutics and improving patient outcomes through innovative research and development.

Xuanwen Li Work